Registration does not represent any form of accreditation, certification or approval by the UK Competent Authority(MHRA).
Where a conformity assessment certificate is listed as expired, existing products already placed on the market prior to the expiry may not be affected by this expiry and can continue to be used. This expiry stops new products being placed on the market until there is a new certificate of conformity.

Back to MHRA

Manufacturer's By Device Cancer antigen 19-9 (CA19-9) IVD control-Cancer antigen 19-9 (CA19-9) IVD control

Displaying 1 to 4 of 4

Page(s) 1

Manufacturer	Address	Authorised Representative	Address	Date Registered	MHRA Reference Number
Abbott GmbH	Max-Planck-Ring 2 Wiesbaden 65205 Germany	Abbott Laboratories Limited	Abbott House Vanwall Business Park Vanwall Road Maidenhead Berkshire SL64XE England United Kingdom	01/24/2023	12352
LGC Clinical Diagnostics Inc.	221 US Route 1 Cumberland Foreside ME 04110 United States	Wellkang Ltd	Enterprise Hub NW Business Complex 1 Beraghmore Road Derry Northern Ireland BT48 8SE Northern Ireland United Kingdom	01/24/2022	22089
NeoMedica doo	Bulevar Svetog Cara Konstantina 82-86 Nis 18103 Serbia	Wellkang Ltd	Enterprise Hub NW Business Complex 1 Beraghmore Road Derry Northern Ireland BT48 8SE Northern Ireland United Kingdom	11/26/2020	11006
Shenzhen New Industries Biomedical Engineering Co. Ltd.	No.23 Jinxiu East Road Pingshan District Shenzhen 518122 China	lotus global co ltd	23 Maine Street Reading Reading RG2 6AG England United Kingdom	04/13/2022	16793

Manufacturer's By Device Cancer antigen 19-9 (CA19-9) IVD control-Cancer antigen 19-9 (CA19-9) IVD control

Contact details